US Glioblastoma Market
US Glioblastoma Market Research Report By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy), By Drug Type (Temozolomide, Bevacizumab, Carmustine, Nivolumab, Lomustine), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy) and By End User (Hospitals, Clinical Research Organizations, Homecare Settings) - Forecast to 2035
US Glioblastoma Market Overview:
As per MRFR analysis, the US Glioblastoma Market Size was estimated at 561.75 (USD Million) in 2023.The US Glioblastoma Market Industry is expected to grow from 594.44 (USD Million) in 2024 to 1,025.18 (USD Million..